CN105998407A - Traditional Chinese medicine for treating residual toxin tapping syndrome type deep multiple abscess disease - Google Patents
Traditional Chinese medicine for treating residual toxin tapping syndrome type deep multiple abscess disease Download PDFInfo
- Publication number
- CN105998407A CN105998407A CN201610535655.8A CN201610535655A CN105998407A CN 105998407 A CN105998407 A CN 105998407A CN 201610535655 A CN201610535655 A CN 201610535655A CN 105998407 A CN105998407 A CN 105998407A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- traditional chinese
- multiple abscess
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/86—Violaceae (Violet family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/483—Gleditsia (locust)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine for treating a residual toxin tapping syndrome type deep multiple abscess disease. The traditional Chinese medicine preparation is characterized by being prepared from, by weight, 8-12 parts of herb of whiteflower violet, 15-20 parts of folium hibisci mutabilis, 20-22 parts of squama manis, 28-32 parts of radix scutellariae, 32-35 parts of coptidis rhizome, 32-35 parts of cornu bubali, 25-28 parts of radix angelica sinensis, 20-25 parts of spina gleditsiae, 12-15 parts of leaves of viola acuminata ledeb, 25-28 parts of roots of common peony and 22-25 parts of radix salviae miltiorrhizae. According to the traditional Chinese medicine, all the raw materials are organically combined together, all the ingredients coordinate with one another and achieve interaction, both symptoms and root causes of the residual toxin tapping syndrome type deep multiple abscess disease can be treated, and the good conditioning effect on a body is achieved. For years, tracking investigation and statistics on 50 cases of patients suffering from the disease show that the cure rate of the medicine reaches 92%.
Description
Present disclosure relates to a kind of Chinese medicine, and the Chinese medicine altering pattern of syndrome multiple abscess disease attacked by a kind of residual poison for the treatment of.
Background technology multiple abscess disease refers to that it is the systemic infection disease showed that transitivity, multiple abscess at deep part of muscle occur.Owing to invading in poison heresy, deficient qi and blood, cause evil poison to be fled, the unrestrained swollen caking in local, color of the leather is as usual, the most bitterly or hypodynia, is apt to occur in the depths that extremity, muscle of trunk are abundant, skin lesion appearing without definite location, can give birth to everywhere, or rise one after another, constantly form multiple abscess in each portion of health.Multiple abscess is different due to the cause of disease, and symptom is different.And having different names, common in clinic have multiple abscess due to heat-damp in summer, multiple abscess due to blood stasis, multiple abscess caused by damp-phlegm etc..Having one or several places myalgia at extremity near-end or trunk when multiple abscess disease starts, unrestrained swollen color is white, the slight fever pressed, and after about 23 days, swelling lifts hot pain substantially, accessible lump.The high heat of companion's shiver with cold, general joint pain, feeling of fullness in the head of having a headache, inappetence etc..Later lump is gradually increased, and the pain increased, and about about 2 weeks, lump centre skin was micro-red and hot, press among soft and should refer to, the diseases such as companion's high fever does not moves back, sweating constantly, thirst with desire to drink.After bursting, pus goes out yellow thick or glues pus in vain, or accompanies blood stasis block.Pus is swollen after going out the most only to disappear, and lump fades, and fever of the body also moves back, and appetite is cumulative, and about through about 2 weeks, pus closes up to the greatest extent and heals.What the present invention mainly studied is, and clinical common residual poison attacks that to alter pattern of syndrome multiple abscess sick, and this pattern of syndrome system scurries into nutrient blood because of the heresy of burning hot poison, and poison heresy is fought mutually with QI and blood, and stasis does not dissipates, and flows in meridians, delays among muscle, and cause QI and blood is not all right and sends out.It is often accompanied by high heat, thirsty, the most then unconsciousness and delirium, constipation, yellowish or reddish urine, red tongue, yellow fur, the symptom such as full and rapid pulse.At present, this disease of western medical treatment takes to take the mode of antibiotics more, cures the symptoms, not the disease, and side effect is very big, and easily forms dependency.
Summary of the invention it is an object of the invention to according to " heat-clearing and toxic substances removing; removing heat from blood dredging collateral " Therapeutic Principle, a kind of residual poison for the treatment of is provided to attack the Chinese medicine altering pattern of syndrome multiple abscess disease, this Chinese medicine is used not only to cure speed fast, can not be relapsed after the healing, and without any side effects, also have good opsonic action to healthy.
For realizing the above-mentioned purpose of the present invention, be the technical scheme is that a kind of residual poison for the treatment of is attacked and altered the Chinese medicine that pattern of syndrome multiple abscess is sick, be it is characterized in that the Chinese medicine preparation being made up of the medical material of following weight proportion: Herba violae patrinii 8 12 parts, Folium Hibisci Mutabilis 15 20 parts, Squama Manis 20 22 parts, Radix Scutellariae 28 32 parts, Rhizoma Coptidis 32 35 parts, Cornu Bubali 32 35 parts, Radix Angelicae Sinensis 25 28 parts, Spina Gleditsiae 20 25 parts, Folium Violae Acuminatae 12 15 parts, Radix Paeoniae Rubra 25 28 parts, Radix Salviae Miltiorrhizae 22 25 parts.The processing technique of the present invention is: various medical material grindings become end, then extracts by conventional method " whole part " and make instant Chinese medicine granule, carry out subpackage according to every pouch 10 grams, airtight, preserves in shady and cool, the place of being dried.Dissolving with boiled water after meal and take, having part insoluble matter is normal phenomenon, and under all taking after mixing, twice on the one (the most once), each one bag, 7 days be a course for the treatment of.Take medicine period, preferably diet is light, avoids tobacco and wine, raw meat, food cold, peppery, strengthens nutrition, and polydipsia boiled water or with fresh Pulp Citrulli juice for tea-drinking, process furuncle, furuncle and skin injury in time, ill after should lie up, in case multiple abscess is sent out at it again, the work and rest keeping good is accustomed to, association's rationally decompression, loosens mood, avoids staying up late as far as possible.
Herba violae patrinii of the present invention has heat-clearing and toxic substances removing, effect of dissipating blood stasis for subsidence of swelling;The Folium Hibisci Mutabilis used has removing heat from blood, removing toxic substances, detumescence, effect of pain relieving;The Squama Manis used has effect of eliminating mass of invigorating blood circulation, the meridian dredging, stimulating milk secretion, detumescence and apocenosis;The Radix Scutellariae used has that heat clearing and damp drying, eliminating fire and detoxication, cooling blood for hemostasis, heat extraction be antiabortive, effect of antiphlogistic antibacterial;The Rhizoma Coptidis used has heat clearing and damp drying, eliminating fire and detoxication, effect of relieving restlessness and preventing vomiting;The Cornu Bubali used has effect of heat clearing away, removing heat from blood, removing toxic substances;The Radix Angelicae Sinensis used has effect of blood-supplementing blood-nourishing, promoting blood circulation to remove blood stasis, regulating menstruation, pain relieving, intestine moistening;The Spina Gleditsiae used has detumescence poison holding, effect of evacuation of pus;The Folium Violae Acuminatae used has effect of heat-clearing and toxic substances removing, reducing swelling and alleviating pain;The Radix Paeoniae Rubra used has effect of heat clearing away, removing heat from blood, hemostasis, YIN nourishing and the production of body fluid promoting;The Radix Salviae Miltiorrhizae used has blood circulation promoting and blood stasis dispelling, menstruction regulating and pain relieving, removing heat from blood eliminating carbuncle, effect of clearing away heart-fire for tranquillization.Any of the above raw material is organically combined by the present invention, mutually coordinated between each composition, interacts, and attacks residual poison and alters the enough treating both the principal and secondary aspects of a disease of pattern of syndrome multiple abscess condition of disease, and has good opsonic action to health.For many years, by the follow-up investigation of 50 these type of patients of example is added up, show that this prescription cure rate reaches 92%.
Below by the basic condition analysis about data, further illustrate the effect of the present invention.
General patient demographic's structure and Cure
Age group (year) | Case load | Occupation | Case load | Healing number | Cure rate |
18—25 | 9 people | Workman | 9 people | 8 people | 89% |
26--30 | 7 people | Businessman | 13 people | 12 people | 92% |
31--35 | 11 people | Cadre | 10 people | 10 people | 100% |
36--40 | 10 people | Peasant | 8 people | 7 people | 88% |
>40 | 13 people | Other | 10 people | 9 people | 90% |
Add up to | 50 people | Add up to | 50 people | 46 people | 92% |
Enumerate three model cases below and further illustrate the effect of the present invention:
1, model, birth in 1979, when 33 years old, myalgia at extremity number occurs, the symptoms such as heat is lifted in swelling, the white symptom of lump color, with high heat, thirsty, red tongue, yellow fur, full and rapid pulse, without organic disease, after be diagnosed as residual poison in here and attack and alter pattern of syndrome multiple abscess disease.After taking 1 course for the treatment of of this prescription, remission, after taking 2 courses for the treatment of, symptom is clearly better, after continue to take and consolidate 1 course for the treatment of after, symptom disappears entirely, recovery from illness.
2, Wang, birth in 1970, when 38 years old, occur luming at trunk number, hard, the pain symptom pressed, with heating, thirsty, constipation, yellowish or reddish urine, red tongue with yellow fur, the symptoms such as full and rapid pulse, without organic disease, after be diagnosed as residual poison in here and attack that to alter pattern of syndrome multiple abscess sick, after taking 1 course for the treatment of of this prescription, symptom has been alleviated, and after 2 courses for the treatment of, symptom disappears entirely, recovery from illness.
3, cold certain, nineteen ninety be born, when 22 years old, myalgia at extremity number occurs, heat is lifted in swelling, and pain is obvious, accessible lump symptom, it is tired of with fever of the body, thirsty god, red tongue, yellow and greasy fur, the symptoms such as full and rapid pulse, without organic disease, after be diagnosed as residual poison in here and attack that to alter pattern of syndrome multiple abscess sick, after taking 1 course for the treatment of of this prescription, symptom is substantially alleviated, and after 2 courses for the treatment of, symptom disappears substantially, after continue again to take 1 course for the treatment of and consolidate, symptom disappears entirely, recovery from illness.
The present invention, for describing the present invention in detail, is done further detailed description below in conjunction with specific embodiment by detailed description of the invention.
Embodiment 1: Herba violae patrinii 8 grams, Folium Hibisci Mutabilis 15 grams, Squama Manis 20 grams, Radix Scutellariae 28 grams, Rhizoma Coptidis 32 grams, Cornu Bubali 32 grams, Radix Angelicae Sinensis 25 grams, Spina Gleditsiae 20 grams, Folium Violae Acuminatae 12 grams, Radix Paeoniae Rubra 25 grams, Radix Salviae Miltiorrhizae 22 grams.Any of the above medical material grinding is become end, then extracts by conventional method " whole part " and make instant Chinese medicine granule, carry out subpackage according to every pouch 10 grams, airtight, preserve in shady and cool, the place of being dried.
Embodiment 2: Herba violae patrinii 10 grams, Folium Hibisci Mutabilis 18 grams, Squama Manis 21 grams, Radix Scutellariae 30 grams, Rhizoma Coptidis 34 grams, Cornu Bubali 34 grams, Radix Angelicae Sinensis 27 grams, Spina Gleditsiae 24 grams, Folium Violae Acuminatae 13 grams, Radix Paeoniae Rubra 26 grams, Radix Salviae Miltiorrhizae 23 grams.Any of the above medical material grinding is become end, then extracts by conventional method " whole part " and make instant Chinese medicine granule, carry out subpackage according to every pouch 10 grams, airtight, preserve in shady and cool, the place of being dried.
Embodiment 3: Herba violae patrinii 12 grams, Folium Hibisci Mutabilis 20 grams, Squama Manis 22 grams, Radix Scutellariae 32 grams, Rhizoma Coptidis 35 grams, Cornu Bubali 35 grams, Radix Angelicae Sinensis 28 grams, Spina Gleditsiae 25 grams, Folium Violae Acuminatae 15 grams, Radix Paeoniae Rubra 28 grams, Radix Salviae Miltiorrhizae 25 grams.Any of the above medical material grinding is become end, then extracts by conventional method " whole part " and make instant Chinese medicine granule, carry out subpackage according to every pouch 10 grams, airtight, preserve in shady and cool, the place of being dried.
Claims (1)
1. treat residual poison and attack and alter the Chinese medicine that pattern of syndrome multiple abscess is sick for one kind, it is characterized in that the Chinese medicine preparation being made up of the medical material of following weight proportion: Herba violae patrinii 8 12 parts, Folium Hibisci Mutabilis 15 20 parts, Squama Manis 20 22 parts, Radix Scutellariae 28 32 parts, Rhizoma Coptidis 32 35 parts, Cornu Bubali 32 35 parts, Radix Angelicae Sinensis 25 28 parts, Spina Gleditsiae 20 25 parts, Folium Violae Acuminatae 12 15 parts, Radix Paeoniae Rubra 25 28 parts, Radix Salviae Miltiorrhizae 22 25 parts.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610535655.8A CN105998407A (en) | 2016-07-09 | 2016-07-09 | Traditional Chinese medicine for treating residual toxin tapping syndrome type deep multiple abscess disease |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610535655.8A CN105998407A (en) | 2016-07-09 | 2016-07-09 | Traditional Chinese medicine for treating residual toxin tapping syndrome type deep multiple abscess disease |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105998407A true CN105998407A (en) | 2016-10-12 |
Family
ID=57109706
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610535655.8A Pending CN105998407A (en) | 2016-07-09 | 2016-07-09 | Traditional Chinese medicine for treating residual toxin tapping syndrome type deep multiple abscess disease |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105998407A (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105663220A (en) * | 2014-11-18 | 2016-06-15 | 张毅 | Traditional Chinese medicine formula for treating deep multiple abscess with syndrome of heat toxin accumulation |
-
2016
- 2016-07-09 CN CN201610535655.8A patent/CN105998407A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105663220A (en) * | 2014-11-18 | 2016-06-15 | 张毅 | Traditional Chinese medicine formula for treating deep multiple abscess with syndrome of heat toxin accumulation |
Non-Patent Citations (1)
Title |
---|
李沧海等,: ""联合方组内外兼治治疗余毒流注1 例报道"", 《中国民间疗法》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103550638B (en) | Traditional Chinese medicine for treating skin itch with syndrome of superficies attacked by wind-heat | |
CN105998407A (en) | Traditional Chinese medicine for treating residual toxin tapping syndrome type deep multiple abscess disease | |
CN105412783A (en) | Traditional Chinese medicine for treating hydropsy caused by interior dampness-heat syndromes | |
CN104225291A (en) | Traditional Chinese medicine for treating intermenstrual aphthous stomatitis due to yin-deficiency and fire-hyperactivity syndromes | |
CN103550736B (en) | Traditional Chinese medicine for treating blood stasis and channel blockage symptom type amenorrhea | |
CN106038902A (en) | Traditional Chinese medicine for treating blood stagnation type deep multiple abscess | |
CN105343364A (en) | Traditional Chinese medicine for treating fire toxin accumulation syndrome type palate carbunculosis | |
CN103816394A (en) | Traditional Chinese medicine for treating postpartum pain of body caused by blood deficiency symptom | |
CN104435511A (en) | Formula of traditional Chinese medicine for treating chronic cholecystitis | |
CN106109734A (en) | A kind of heat-damp in summer for the treatment of hands over the Chinese medicine of resistance pattern of syndrome multiple abscess disease | |
CN105311215A (en) | Medicine for treating dermatitis | |
CN105998367A (en) | Traditional Chinese medicine for treating wind-fire-heat-toxin-syndrome-type maxillary bone osteomyelitis disease | |
CN106038980A (en) | Traditional Chinese medicine for treating yin deficiency and exuberant fire type inguinal carbuncle | |
CN106038815A (en) | Traditional Chinese medicine for treating toxin predominance pyogenesis syndrome type parotitis phlegmonosa | |
CN102631653B (en) | Method for preparing traditional Chinese medicine (TCM) lotion for treating spleen deficiency type pustule on sole | |
CN105998586A (en) | Traditional Chinese medicine for treating heat-toxin-flourishing-syndrome-type inguinal carbuncle disease | |
CN106177218A (en) | A kind of pyretic toxicity for the treatment of pents up the Chinese medicine that pattern of syndrome maxillofacial sore is sick | |
CN105998624A (en) | Traditional Chinese medicine for treating yin deficiency and blood dryness syndrome type nasal eczema disease | |
CN105998906A (en) | Traditional Chinese medicine for treating damp-heat stagnation syndrome type inguinal carbuncle disease | |
CN106039191A (en) | Traditional Chinese medicine for treating gravity abscess with syndrome of phlegm-dampness due to spleen deficiency | |
CN105998366A (en) | Traditional Chinese medicine for treating exuberant evil heat syndrome type maxillary osteomyelitis disease | |
CN105998905A (en) | Traditional Chinese medicine for treating spleen-and-stomach-maladjusting damp-hot-stagnation-steaming-syndrome-type nasal eczema disease | |
CN105998344A (en) | Traditional Chinese medicine for treating qi-deficiency-toxin-stagnation-syndrome-type maxillary bone osteomyelitis disease | |
CN106166216A (en) | A kind of Chinese medicine treating damp-heat accumulation pattern of syndrome erythema multiforme disease | |
CN106039013A (en) | Traditional Chinese medicine for treating acute retroauricular lymphadenitis diseases with syndromes of toxic fire invading ears |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20161012 |